LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome.

    Fiorini, Giulia / Saracino, Ilaria M / Pavoni, Matteo / Nipote, Bruno / Colucci, Raffaele / Capone, Pietro / Sannino, Angela / Forte, Fabrizio / DE Vergori, Emiliano / Brancaccio, Mario / Cesareo, Maurizio / Casella, Giovanni / Morreale, Gaetano C / Bonfrate, Leonilde / Portincasa, Piero / Vincenzi, Massimo / Cottone, Carmelo / Ormando, Vittorio M / Scalise, Natale /
    Lawson, Paulin F / Burattini, Osvaldo / Montale, Amedeo / Luzza, Francesco / Rossi, Mauro / Vanni, Riccardo / Bozzi, Rosamaria / Vincoli, Giuseppina / Stefani, Nicoletta / Borghi, Claudio / Vaira, Dino

    Minerva gastroenterology

    2023  Volume 69, Issue 1, Page(s) 123–127

    Abstract: Background: Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders. IBS is characterized by recurrent chronic abdominal pain and altered bowel habits in the absence of organic damage. Although there are reviews ... ...

    Abstract Background: Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders. IBS is characterized by recurrent chronic abdominal pain and altered bowel habits in the absence of organic damage. Although there are reviews and guidelines for treating IBS, the complexity and diversity of IBS presentation make treatment difficult. Treatment of IBS focuses on relieving symptoms as mild signs and symptoms can often be controlled by managing stress and by making changes in diet and lifestyle. The use of nutraceutical compounds has been advocated as a possible alternative treatment in patients with IBS. COLONIR
    Methods: An initial cohort of 1004 consecutive patients referred to 25 different Units of Internal Medicine a/o Gastroenterology in Italy to perform colonoscopy for intestinal symptoms was asked to participate. Patients were treated for 2 months with two doses of nutraceuticals/day during meals namely COLONIR
    Results: After 2 months, 899 patients completed the follow-up. COLONIR
    Conclusions: These promising results, here reported, need to be confirmed, valuating the efficacy of COLONIR
    MeSH term(s) Humans ; Irritable Bowel Syndrome/complications ; Irritable Bowel Syndrome/drug therapy ; Charcoal ; Tryptophan ; Chamomile ; Glycyrrhiza ; Mentha ; Dietary Supplements ; Gastrointestinal Diseases ; Probiotics ; Abdominal Pain/drug therapy ; Abdominal Pain/etiology ; Flower Essences ; Chronic Pain
    Chemical Substances Charcoal (16291-96-6) ; Tryptophan (8DUH1N11BX) ; Flower Essences
    Language English
    Publishing date 2023-03-01
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 3062713-8
    ISSN 2724-5365
    ISSN (online) 2724-5365
    DOI 10.23736/S2724-5985.22.03282-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).

    Hogarth, Penelope / Kurian, Manju A / Gregory, Allison / Csányi, Barbara / Zagustin, Tamara / Kmiec, Tomasz / Wood, Patricia / Klucken, Angelika / Scalise, Natale / Sofia, Francesca / Klopstock, Thomas / Zorzi, Giovanna / Nardocci, Nardo / Hayflick, Susan J

    Molecular genetics and metabolism

    2017  Volume 120, Issue 3, Page(s) 278–287

    MeSH term(s) Adolescent ; Adult ; Child ; Humans ; Iron Chelating Agents/therapeutic use ; Pantothenate Kinase-Associated Neurodegeneration/diagnosis ; Pantothenate Kinase-Associated Neurodegeneration/drug therapy ; Pantothenate Kinase-Associated Neurodegeneration/genetics ; Pantothenic Acid/therapeutic use ; Phosphotransferases (Alcohol Group Acceptor)/genetics ; Practice Guidelines as Topic
    Chemical Substances Iron Chelating Agents ; Pantothenic Acid (19F5HK2737) ; Phosphotransferases (Alcohol Group Acceptor) (EC 2.7.1.-) ; pantothenate kinase (EC 2.7.1.33)
    Language English
    Publishing date 2017
    Publishing country United States
    Document type Consensus Development Conference ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1418518-0
    ISSN 1096-7206 ; 1096-7192
    ISSN (online) 1096-7206
    ISSN 1096-7192
    DOI 10.1016/j.ymgme.2016.11.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top